Group 1 - The closing price of Canan Co., Ltd. on May 14 was 19.99 yuan, down 2.06%, with a rolling PE ratio of 68.40 times and a total market value of 2.444 billion yuan [1] - In the medical device industry, the average PE ratio is 49.84 times, and the median is 36.65 times, placing Canan Co., Ltd. at the 98th position in the industry ranking [1] - The main business of Canan Co., Ltd. includes the research, production, and sales of injection puncture instruments and laboratory consumables, with key products being medical devices, animal instruments, and laboratory consumables [1] Group 2 - For the first quarter of 2025, Canan Co., Ltd. reported operating revenue of 72.7093 million yuan, a year-on-year decrease of 34.28%, and a net profit of 7.6802 million yuan, down 69.34% year-on-year, with a gross profit margin of 31.15% [1] - The company has been recognized as a specialized and innovative small and medium-sized enterprise in Jiangsu Province and a provincial-level leading enterprise in agricultural industrialization [1]
采纳股份收盘下跌2.06%,滚动市盈率68.40倍,总市值24.44亿元